NatureWise Biotech & Medicals Corporation (TPEX:4732)

Market Cap	930.65M -16.5%
Revenue (ttm)	180.29M -19.7%
Net Income	-37.01M
EPS	-0.75
Shares Out	47.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,838
Average Volume	29,589
Open	19.80
Previous Close	19.80
Day's Range	19.45 - 19.80
52-Week Range	17.40 - 27.85
Beta	0.68
RSI	46.94
Earnings Date	Mar 30, 2026

About TPEX:4732

NatureWise Biotech & Medicals Corporation engages in the research and development of Western medicine, Chinese medicine, and biotechnology in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; and green propolis and red yeast rice products. The company was founded in 1990 and is headquartered in Taipei, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 32
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4732

Financial Performance

In 2024, TPEX:4732's revenue was 224.32 million, an increase of 40.08% compared to the previous year's 160.14 million. Earnings were 897,000, a decrease of -91.14%.